Dongsin Engineering & Construction (KOSDAQ:025950)
10,070
-200 (-1.95%)
At close: Aug 24, 2026
KOSDAQ:025950 Revenue
Dongsin Engineering & Construction had revenue of 5.66B KRW in the quarter ending March 31, 2026, a decrease of -5.08%. This brings the company's revenue in the last twelve months to 33.08B, down -46.46% year-over-year. In the year 2025, Dongsin Engineering & Construction had annual revenue of 33.38B, down -51.60%.
Revenue (ttm)
33.08B
Revenue Growth
-46.46%
P/S Ratio
2.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
84.59B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.38B | -35.59B | -51.60% |
| Dec 31, 2024 | 68.97B | -13.77B | -16.64% |
| Dec 31, 2023 | 82.74B | 32.44B | 64.50% |
| Dec 31, 2022 | 50.30B | -7.13B | -12.42% |
| Dec 31, 2021 | 57.43B | 21.93B | 61.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sy Co., Ltd. | 511.55B |
| Kumyang Green Power | 318.59B |
| Osung Advanced Materials | 166.43B |
| JLS Co.,Ltd. | 102.39B |
| KOREA PHARMA | 93.94B |
| Nice D&B | 92.02B |
| Victek | 88.93B |
| Sam-A Pharm. | 72.28B |